Catalyst Wire Dossier Catalyst Wire Dossier

SPIRIVA RESPIMAT

tiotropium bromide inhalation spray · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for SPIRIVA RESPIMAT, covering 2010-03-12 to 2024-12-27. Get the full timeline:

Most recent: FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing